UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549
                                    FORM 8-K

                                 CURRENT REPORT

     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

       Date of Report (date of earliest event reported): August 14, 2013

                               PROMAP CORPORATION
                    ----------------------------------------
             (Exact name of registrant as specified in its charter)

      Colorado                          None                     20-8096131
  ----------------------          -----------------          -----------------
(State or other jurisdiction    (Commission File No.)       (IRS Employer
  of incorporation)                                          Identification No.)

                         7750 N. Union Blvd., Suite 210
                           Colorado Springs, CO 80920
        ----------------------------------------------------------------
          (Address of principal executive offices, including Zip Code)

       Registrant's telephone number, including area code: (719) 590-1414

                          6855 S. Havana St., Suite 400
                              Centennial, CO 80112
            -------------------------------------------------------
          (Former name or former address if changed since last report)

Check appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy  the filing  obligation  of the  registrant  under any of the  following
provisions (see General Instruction A.2. below)

[] Written communications pursuant to Rule 425 under the Securities Act (17 CFR
   230.425)

[] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
   240.14a-12)

[] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
   Act (17 CFR 240.14d-2(b))

[] Pre-commencement communications pursuant to Rule 13e-14(c) under the Exchange
   Act (17 CFR 240.13e-4(c))

<PAGE>

Item 1.01. Entry into a Material Definitive Agreement.

     On  August  14,  2013,   pursuant  to  a  Share  Exchange   Agreement  (the
"Agreement"),  Promap Corporation (the "Company") acquired  approximately 94% of
the outstanding  common stock of Advanced  Cannabis  Solutions,  Inc. ("ACS") in
exchange for 12,100,000 shares of the Company's common stock.

     In connection with the acquisition:

     o    the Company caused 8,000,000 shares of its outstanding common stock to
          be cancelled;

     o    Robert  Frichtel  was  appointed  as  a  director  and  the  Principal
          Executive and Financial Officer of the Company;

     o    Roberto Lopesino was appointed Vice President of the Company; and

     o    Steven Tedesco and Robert  Carrington,  Jr.,  resigned as officers and
          directors of the Company.

     As a result  of the  acquisition,  ACS is the  Corporation's  wholly  owned
subsidiary  and the  former  shareholders  of ACS own  approximately  88% of the
Company's common stock.  The Company plans to acquire the remaining  outstanding
shares of ACS at a later date.

     Unless  otherwise  indicated  all  references  to the  Company  include the
operations of the Company and ACS.

     ACS was  incorporated  in Colorado on June 5, 2013.  As of the date of this
report, ACS had not commenced operations.

     Information regarding Mr. Frichtel and Mr. Lopesino is shown below.

     Robert L.  Frichtel,  age 49 served as a managing  partner  of IBC  Capital
Group, a commercial real estate and finance  company,  since 2002.  Between 1999
and 2001,  Mr.  Frichtel was the  president and Chief  Operating  Officer of EOS
Group, a division of Health Net, a NYSE listed  healthcare  company.  Since 2001
Mr. Frichtel has consulted for numerous  clients  throughout the nation that are
engaged in the medical marijuana business and has written articles for Bloomberg
business  regarding the cannabis  industry.  Mr. Frichtel received a Bachelor of
Science  degree in business  administrative  from Colorado  State  University in
1985.

     Roberto  Lopesino,  age 35,  since March 2013,  has  operated a  consulting
business that studies and monitors the medical  marijuana market in Colorado and
consults to the  industry on market  pricing and trends.  Since April 2011,  Mr.
Lopesino  has  operated a  non-brokered  commodities  market for the  commercial
production of medical grade  marijuana.  Between  August 2010 and March 2011, he
was the owner and manager of North Boulder Wellness Center in Boulder, Colorado,
a multi-site medical dispensary and producer of marijuana. Between November 2007

                                       2
<PAGE>

and March 2010, Mr. Lopesino operated and managed a company specializing in deep
powder  snowcat and heli skiing in the San Juan mountain  range of Colorado.  In
February  2006,  Mr.  Lopesino  founded,  and until  December  2007  operated  a
multilingual title company  specializing in real estate document preparation and
closings.  Mr.  Lopesino  studied  engineering  at  Purdue  University  and  the
University of Colorado in Boulder.

     The following  shows the amounts the Company expects to pay to its officers
during  the  twelve  months  ending  July 31,  2014 and the amount of time these
persons expect to devote to the Company.

                                                            % of time
                                Projected                to be devoted to
       Name                    Compensation             Company's business
       ----                    ------------             ------------------

      Robert L. Frichtel         $108,000                      100%
      Roberto Lopesino           $108,000                      100%

     The  Company's  directors  serve  until  the  next  annual  meeting  of the
Company's  shareholders  and until their  successors  have been duly elected and
qualified.  The  Company's  officers  serve at the  discretion  of the Company's
directors.  The Company does not compensate any person for acting as a director.
The Company's  current officers and directors were elected to their positions in
June 2013.

Principal Shareholders

     The following table shows the ownership,  as of the date of this report, of
those persons owning  beneficially 5% or more of the Company's  common stock and
the number and percentage of  outstanding  shares owned by each of the Company's
directors  and officers and by all  officers  and  directors as a group.  Unless
otherwise indicated,  each owner has sole voting and investment power over their
shares of common stock.

      Name                        Shares Owned     % of Outstanding Shares
      ----                        ------------     -----------------------

      Robert L. Frichtel           1,000,000               7.2%

      Roberto Lopesino             1,150,000               8.3%

Proposed Business

     The Company plans to lease growing space and related facilities to licensed
marijuana growers and dispensary owners for their operations.  Additionally, the
Company  plans to  provide a  variety  of  services  to the  cannabis  industry,
including a medical marijuana research and new product  development  laboratory.
The Company will not harvest, distribute or sell cannabis or any substances that
violate United States law or the Controlled  Substances  Act, nor does it intend
to do so in the future.

     The Company  plans to acquire two  properties  for the initial phase of its
business.

                                       3
<PAGE>

     The first property is a 90 acre parcel of land near Pueblo,  Colorado.  The
Company estimates that the Pueblo property will cost  approximately  $3,000,000,
with  $1,300,000  payable at closing and  $1,700,000  payable  over a three-year
period.  If the  Company is  successful  in  acquiring  the  property,  which is
permitted for the legal growing of marijuana for medical  purposes,  the Company
plans to spend approximately $1,800,000 for the construction of a facility which
will be leased to medical marijuana growers.  The proposed facility will include
specialized  equipment necessary to allow for the use of the facility by medical
marijuana  dispensaries.  The  facility  will  have  indoor  greenhouse  growing
facilities,  as  well  as  a  research,  testing  and  new  product  development
laboratory.  Tenants  will pay rent and other fees to the Company for the use of
the facility.

     The  second  property  is a 9-acre  parcel  located in  Boulder,  Colorado.
Improvements  on the property  consist of a 40,000 square foot  greenhouse and a
2,000 square foot building, with 8 undeveloped acres. This property is presently
leased  until  August,  2014 to a state  licensed  cannabis  dispensary.  If the
Company is successful in acquiring this property,  the Company is of the opinion
that it can negotiate a new lease on the property which would provide for rental
income of approximately $130,000 each month to the Company.

     The Boulder property will cost  approximately  $6,500,000,  with $4,500,000
payable at closing and $2,000,000 payable over a three-year period.

     The Company refers to its proposed growing facilities as Cannabis Campuses.
The Cannabis  Campuses  will offer  dispensary  owners the  opportunity  to grow
marijuana  in a  controlled  setting  without  the  costs  associated  with  the
implementation of an expensive and difficult to manage growing facility.

     If successful,  the Company plans to reproduce the Cannabis  Campus concept
in other locations in Colorado, as well as other states.

     There can be no  assurance  that the  Company  will be able to  obtain  the
capital needed to purchase the properties.

Market Conditions

     In  Colorado  (with 5.1  million  residents),  the 2013  medical  marijuana
market,  with approximately 500 licensed  dispensaries and 110,000 legal medical
users, is believed to be $200,000,000.

     While projections vary widely,  many believe that when legalization  occurs
in 2014,  the  Colorado  medical and  recreational  market  combined  will reach
$600,000,000 (according to Colorado State University).

     In Colorado,  the market will be expanded in January 2014 to include  adult
use, including  visitors from other states.  Voters in Washington state recently
approved a ballot  measure to  legalize  cannabis  for adult use.  Many  experts

                                       4
<PAGE>

predict  that other  states  will follow  Colorado  and  Washington  in enacting
legislation  or  approving  ballot  measures  that expand the  permitted  use of
cannabis.

Government Regulation

     Marijuana is a Schedule-I controlled substance and is illegal under federal
law. Even in those states in which the use of marijuana has been legalized,  its
use remains a violation of federal laws.

     As of July 31,  2013,  18 states and the  District  of  Columbia  allow its
citizens  to use  Medical  Marijuana.  Additionally,  voters  in the  states  of
Colorado and  Washington  approved  ballot  measures  last  November to legalize
cannabis  for  adult  use.  The  state  laws are in  conflict  with the  federal
Controlled Substances Act, which makes marijuana use and possession illegal on a
national level. The Obama  administration  has effectively stated that it is not
an efficient use of resources to direct law federal law enforcement  agencies to
prosecute those lawfully abiding by  state-designated  laws allowing the use and
distribution  of medical  marijuana.  However,  there is no  guarantee  that the
administration  will not change its stated  policy  regarding  the  low-priority
enforcement of federal laws.  Additionally,  any new administration that follows
could  change this policy and decide to enforce the federal laws  strongly.  Any
such change in the federal  government's  enforcement  of current  federal  laws
could cause significant financial damage to ACS and its shareholders.  While ACS
does not intend to  harvest,  distribute  or sell  cannabis,  the Company may be
irreparably  harmed  by  a  change  in  enforcement  by  the  Federal  of  state
governments.

General

     The Company is leasing this space for $1,000 per month until December 2015.
The Company's  offices are located at 7750 N. Union Blvd.,  Suite 210,  Colorado
Springs,  Colorado 80920. The Company's telephone number is (719) 590-1414.  The
Company's fax number is (719) 590-4888.

     As of August 14, 2013 the Company did not have any full time employees.

     The Company plans to change its name to Advanced Cannabis Solutions, Inc.

Item 2.01.  Completion of Acquisition or Disposition of Assets.

     See Item 1.01 of this report.

Item 3.02.  Unregistered Sale of Equity Securities.

     In connection with the issuance of the 13,650,000  shares described in Item
1.01 of this report,  the Company relied upon the exemption  provided by Section
4(2) of the  Securities  Act of 1933. The persons who acquired these shares were
sophisticated  investors  and  were  provided  full  information  regarding  the
Company's  business  and  operations.  There  was  no  general  solicitation  in
connection with the offer or sale of these securities.  The persons who acquired

                                       5
<PAGE>

these shares acquired them for their own accounts. The certificates representing
these shares bear a restricted  legend providing that they cannot be sold except
pursuant  to  an  effective   registration   statement  or  an  exemption   from
registration.  No commission was paid to any person in connection  with the sale
of these shares.

Item 5.01.  Change in Control of Registrant.

     See Item 1.01 of this report.

Item 5.02.  Departure of Directors or Certain Officers;  Election of Directors;
            Appointment of Certain Officers; Compensatory Arrangements of
            Certain Officers.

     See Item 1.01 of this report.

Item 9.01.  Financial Statements and Exhibits.

No.         Description

10          Share Exchange Agreement with
            Advanced Cannabis Solutions, Inc.

                                       6
<PAGE>

                                   SIGNATURES

     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.


Date: August 15, 2013
                                        PROMAP CORPORATION


                                       By:/s/ Robert L. Fritchel
                                          --------------------------------
                                          Robert L. Frichtel, Chief Executive
                                             Officer





                                       7
[{"type": "8-K", "sequence": "1", "filename": "form8kitem101aug-13.txt", "description": "8-K RE ACS ACQUISITION", "secsgml_size_bytes": 14943}]
{"company-data": {"conformed-name": "Promap Corp", "cik": "0001477009", "assigned-sic": "1389", "irs-number": "208096131", "state-of-incorporation": "CO", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-54457", "film-number": "131044539"}, "business-address": {"street1": "6855 SOUTH HAVANA STREET", "street2": "SUITE 400", "city": "CENTENNIAL", "state": "CO", "zip": "80112", "phone": "(720) 889-0510"}, "mail-address": {"street1": "6855 SOUTH HAVANA STREET", "street2": "SUITE 400", "city": "CENTENNIAL", "state": "CO", "zip": "80112"}}
UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549
                                    FORM 8-K

                                 CURRENT REPORT

     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

       Date of Report (date of earliest event reported): August 14, 2013

                               PROMAP CORPORATION
                    ----------------------------------------
             (Exact name of registrant as specified in its charter)

      Colorado                          None                     20-8096131
  ----------------------          -----------------          -----------------
(State or other jurisdiction    (Commission File No.)       (IRS Employer
  of incorporation)                                          Identification No.)

                         7750 N. Union Blvd., Suite 210
                           Colorado Springs, CO 80920
        ----------------------------------------------------------------
          (Address of principal executive offices, including Zip Code)

       Registrant's telephone number, including area code: (719) 590-1414

                          6855 S. Havana St., Suite 400
                              Centennial, CO 80112
            -------------------------------------------------------
          (Former name or former address if changed since last report)

Check appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy  the filing  obligation  of the  registrant  under any of the  following
provisions (see General Instruction A.2. below)

[] Written communications pursuant to Rule 425 under the Securities Act (17 CFR
   230.425)

[] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
   240.14a-12)

[] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
   Act (17 CFR 240.14d-2(b))

[] Pre-commencement communications pursuant to Rule 13e-14(c) under the Exchange
   Act (17 CFR 240.13e-4(c))
Item 1.01. Entry into a Material Definitive Agreement.

     On  August  14,  2013,   pursuant  to  a  Share  Exchange   Agreement  (the
"Agreement"),  Promap Corporation (the "Company") acquired  approximately 94% of
the outstanding  common stock of Advanced  Cannabis  Solutions,  Inc. ("ACS") in
exchange for 12,100,000 shares of the Company's common stock.

     In connection with the acquisition:

     o    the Company caused 8,000,000 shares of its outstanding common stock to
          be cancelled;

     o    Robert  Frichtel  was  appointed  as  a  director  and  the  Principal
          Executive and Financial Officer of the Company;

     o    Roberto Lopesino was appointed Vice President of the Company; and

     o    Steven Tedesco and Robert  Carrington,  Jr.,  resigned as officers and
          directors of the Company.

     As a result  of the  acquisition,  ACS is the  Corporation's  wholly  owned
subsidiary  and the  former  shareholders  of ACS own  approximately  88% of the
Company's common stock.  The Company plans to acquire the remaining  outstanding
shares of ACS at a later date.

     Unless  otherwise  indicated  all  references  to the  Company  include the
operations of the Company and ACS.

     ACS was  incorporated  in Colorado on June 5, 2013.  As of the date of this
report, ACS had not commenced operations.

     Information regarding Mr. Frichtel and Mr. Lopesino is shown below.

     Robert L.  Frichtel,  age 49 served as a managing  partner  of IBC  Capital
Group, a commercial real estate and finance  company,  since 2002.  Between 1999
and 2001,  Mr.  Frichtel was the  president and Chief  Operating  Officer of EOS
Group, a division of Health Net, a NYSE listed  healthcare  company.  Since 2001
Mr. Frichtel has consulted for numerous  clients  throughout the nation that are
engaged in the medical marijuana business and has written articles for Bloomberg
business  regarding the cannabis  industry.  Mr. Frichtel received a Bachelor of
Science  degree in business  administrative  from Colorado  State  University in
1985.

     Roberto  Lopesino,  age 35,  since March 2013,  has  operated a  consulting
business that studies and monitors the medical  marijuana market in Colorado and
consults to the  industry on market  pricing and trends.  Since April 2011,  Mr.
Lopesino  has  operated a  non-brokered  commodities  market for the  commercial
production of medical grade  marijuana.  Between  August 2010 and March 2011, he
was the owner and manager of North Boulder Wellness Center in Boulder, Colorado,
a multi-site medical dispensary and producer of marijuana. Between November 2007

                                       2
and March 2010, Mr. Lopesino operated and managed a company specializing in deep
powder  snowcat and heli skiing in the San Juan mountain  range of Colorado.  In
February  2006,  Mr.  Lopesino  founded,  and until  December  2007  operated  a
multilingual title company  specializing in real estate document preparation and
closings.  Mr.  Lopesino  studied  engineering  at  Purdue  University  and  the
University of Colorado in Boulder.

     The following  shows the amounts the Company expects to pay to its officers
during  the  twelve  months  ending  July 31,  2014 and the amount of time these
persons expect to devote to the Company.

                                                            % of time
                                Projected                to be devoted to
       Name                    Compensation             Company's business
       ----                    ------------             ------------------

      Robert L. Frichtel         $108,000                      100%
      Roberto Lopesino           $108,000                      100%

     The  Company's  directors  serve  until  the  next  annual  meeting  of the
Company's  shareholders  and until their  successors  have been duly elected and
qualified.  The  Company's  officers  serve at the  discretion  of the Company's
directors.  The Company does not compensate any person for acting as a director.
The Company's  current officers and directors were elected to their positions in
June 2013.

Principal Shareholders

     The following table shows the ownership,  as of the date of this report, of
those persons owning  beneficially 5% or more of the Company's  common stock and
the number and percentage of  outstanding  shares owned by each of the Company's
directors  and officers and by all  officers  and  directors as a group.  Unless
otherwise indicated,  each owner has sole voting and investment power over their
shares of common stock.

      Name                        Shares Owned     % of Outstanding Shares
      ----                        ------------     -----------------------

      Robert L. Frichtel           1,000,000               7.2%

      Roberto Lopesino             1,150,000               8.3%

Proposed Business

     The Company plans to lease growing space and related facilities to licensed
marijuana growers and dispensary owners for their operations.  Additionally, the
Company  plans to  provide a  variety  of  services  to the  cannabis  industry,
including a medical marijuana research and new product  development  laboratory.
The Company will not harvest, distribute or sell cannabis or any substances that
violate United States law or the Controlled  Substances  Act, nor does it intend
to do so in the future.

     The Company  plans to acquire two  properties  for the initial phase of its
business.

                                       3
The first property is a 90 acre parcel of land near Pueblo,  Colorado.  The
Company estimates that the Pueblo property will cost  approximately  $3,000,000,
with  $1,300,000  payable at closing and  $1,700,000  payable  over a three-year
period.  If the  Company is  successful  in  acquiring  the  property,  which is
permitted for the legal growing of marijuana for medical  purposes,  the Company
plans to spend approximately $1,800,000 for the construction of a facility which
will be leased to medical marijuana growers.  The proposed facility will include
specialized  equipment necessary to allow for the use of the facility by medical
marijuana  dispensaries.  The  facility  will  have  indoor  greenhouse  growing
facilities,  as  well  as  a  research,  testing  and  new  product  development
laboratory.  Tenants  will pay rent and other fees to the Company for the use of
the facility.

     The  second  property  is a 9-acre  parcel  located in  Boulder,  Colorado.
Improvements  on the property  consist of a 40,000 square foot  greenhouse and a
2,000 square foot building, with 8 undeveloped acres. This property is presently
leased  until  August,  2014 to a state  licensed  cannabis  dispensary.  If the
Company is successful in acquiring this property,  the Company is of the opinion
that it can negotiate a new lease on the property which would provide for rental
income of approximately $130,000 each month to the Company.

     The Boulder property will cost  approximately  $6,500,000,  with $4,500,000
payable at closing and $2,000,000 payable over a three-year period.

     The Company refers to its proposed growing facilities as Cannabis Campuses.
The Cannabis  Campuses  will offer  dispensary  owners the  opportunity  to grow
marijuana  in a  controlled  setting  without  the  costs  associated  with  the
implementation of an expensive and difficult to manage growing facility.

     If successful,  the Company plans to reproduce the Cannabis  Campus concept
in other locations in Colorado, as well as other states.

     There can be no  assurance  that the  Company  will be able to  obtain  the
capital needed to purchase the properties.

Market Conditions

     In  Colorado  (with 5.1  million  residents),  the 2013  medical  marijuana
market,  with approximately 500 licensed  dispensaries and 110,000 legal medical
users, is believed to be $200,000,000.

     While projections vary widely,  many believe that when legalization  occurs
in 2014,  the  Colorado  medical and  recreational  market  combined  will reach
$600,000,000 (according to Colorado State University).

     In Colorado,  the market will be expanded in January 2014 to include  adult
use, including  visitors from other states.  Voters in Washington state recently
approved a ballot  measure to  legalize  cannabis  for adult use.  Many  experts

                                       4
predict  that other  states  will follow  Colorado  and  Washington  in enacting
legislation  or  approving  ballot  measures  that expand the  permitted  use of
cannabis.

Government Regulation

     Marijuana is a Schedule-I controlled substance and is illegal under federal
law. Even in those states in which the use of marijuana has been legalized,  its
use remains a violation of federal laws.

     As of July 31,  2013,  18 states and the  District  of  Columbia  allow its
citizens  to use  Medical  Marijuana.  Additionally,  voters  in the  states  of
Colorado and  Washington  approved  ballot  measures  last  November to legalize
cannabis  for  adult  use.  The  state  laws are in  conflict  with the  federal
Controlled Substances Act, which makes marijuana use and possession illegal on a
national level. The Obama  administration  has effectively stated that it is not
an efficient use of resources to direct law federal law enforcement  agencies to
prosecute those lawfully abiding by  state-designated  laws allowing the use and
distribution  of medical  marijuana.  However,  there is no  guarantee  that the
administration  will not change its stated  policy  regarding  the  low-priority
enforcement of federal laws.  Additionally,  any new administration that follows
could  change this policy and decide to enforce the federal laws  strongly.  Any
such change in the federal  government's  enforcement  of current  federal  laws
could cause significant financial damage to ACS and its shareholders.  While ACS
does not intend to  harvest,  distribute  or sell  cannabis,  the Company may be
irreparably  harmed  by  a  change  in  enforcement  by  the  Federal  of  state
governments.

General

     The Company is leasing this space for $1,000 per month until December 2015.
The Company's  offices are located at 7750 N. Union Blvd.,  Suite 210,  Colorado
Springs,  Colorado 80920. The Company's telephone number is (719) 590-1414.  The
Company's fax number is (719) 590-4888.

     As of August 14, 2013 the Company did not have any full time employees.

     The Company plans to change its name to Advanced Cannabis Solutions, Inc.

Item 2.01.  Completion of Acquisition or Disposition of Assets.

     See Item 1.01 of this report.

Item 3.02.  Unregistered Sale of Equity Securities.

     In connection with the issuance of the 13,650,000  shares described in Item
1.01 of this report,  the Company relied upon the exemption  provided by Section
4(2) of the  Securities  Act of 1933. The persons who acquired these shares were
sophisticated  investors  and  were  provided  full  information  regarding  the
Company's  business  and  operations.  There  was  no  general  solicitation  in
connection with the offer or sale of these securities.  The persons who acquired

                                       5
these shares acquired them for their own accounts. The certificates representing
these shares bear a restricted  legend providing that they cannot be sold except
pursuant  to  an  effective   registration   statement  or  an  exemption   from
registration.  No commission was paid to any person in connection  with the sale
of these shares.

Item 5.01.  Change in Control of Registrant.

     See Item 1.01 of this report.

Item 5.02.  Departure of Directors or Certain Officers;  Election of Directors;
            Appointment of Certain Officers; Compensatory Arrangements of
            Certain Officers.

     See Item 1.01 of this report.

Item 9.01.  Financial Statements and Exhibits.

No.         Description

10          Share Exchange Agreement with
            Advanced Cannabis Solutions, Inc.

                                       6
SIGNATURES

     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

Date: August 15, 2013
                                        PROMAP CORPORATION

                                       By:/s/ Robert L. Fritchel
                                          --------------------------------
                                          Robert L. Frichtel, Chief Executive
                                             Officer

                                       7